Emerald Clinics Expands Into UK’s Over Regulated Medical Cannabis Market
Australian medical cannabis company Emerald Clinics has partnered with Canopy Growth, aiming to introduce a ‘real-world evidence’ system into the UK. Keep Reading
AusCann Impresses Investors With New Drug and New CEO
Medical cannabis company AusCann has had a busy quarter, after releasing their first medication, appointing a new CEO and expanding their educational programs all at once. Keep Reading
International Medical Cannabis Patient Registry ‘Project Twenty21’ Goes Live
Medical cannabis patients in Australia will be part of a historic study, as radical new healthcare study ‘Project Twenty21’ officially begins. Keep Reading
Australian Drug Council Says “Medical Marijuana Does Not Exist”
Despite the Australian government’s increasingly progressive stance on medical cannabis, the Drug Advisory Council of Australia (DACA) has left some rather regressive resources on the website. Keep Reading
$50 Million Hemp Fibre Processing Facility To Be Built In NSW
Australia is due to get our first hemp fibre processing facility, headed by medical cannabis pioneer Langdon Brown. Keep Reading
Policing Cannabis Costs Australia $1.1 Billion Every Year
A new study has explored the true cost of cannabis – finding that policing cannabis is costing Australia over $1 billion every year. Keep Reading
UQ Research Shows Young Australians Would Try Cannabis If It Were Legal
New research has shown that 13-15% of young Australians would try cannabis if it the recreational use of cannabis was legalised. Keep Reading
Medical Cannabis Barriers Too High For Australian Businesses To Climb
Although the production of medical cannabis has been legal Australia-wide since 2016, expensive fees and permit costs are preventing small businesses from entering the rapidly growing industry. Keep Reading
Elixinol Enters Australia’s Cannabis Market With PharmaCann Partnership
A new medication will soon be made available to patients with medical cannabis prescriptions. Australia’s Therapeutic Goods Administration (TGA) has approved the sale of a range of internationally renowned CBD products, which will be available to Australians on the Special Access Scheme by the end of 2020. Keep Reading
Sydney Researchers Find New Cannabis Strain ‘Eve’ Kills Cancer Cells
While cannabis is currently a controlled substance, the drug may play a major role in the cancer treatments of the future. New research released this week has revealed that a strain of cannabis has proven to harm cancer cells, without hurting the healthy tissue in the body. Keep Reading